sharetips
50 posts


Re. potential value it’s always worth going back to MM’s thread. If #AVCT can demonstrate safety + efficacy and - as the CEO put it - “succeed where so many have failed” then sales projections in 2029 will be north of $4Bn.
Apply a x5 multiple = an FT front page in Q4 2022.
Myles McNulty@MylesMcNulty
...had its first ADC authorized by the FDA. It had so far racked up sales of only $20m, before $GILD swooped in. It valued Immunomedics at over 5x peak sales of $4bn (estimated to be reached in 2029!). 24/25 cen.acs.org/pharmaceutical…
English

P1a - “receive escalating doses…until disease progression occurs”
Disease progression - “cancer has grown by at least 20% or there are new areas of cancer”
Unfortunately we know the selfless patients in #AVCT’s trial are all near end of life [at least pancreatic (C1) all were]


English

PF Update.
#88e took some profit into #echo #oex #ukog...but carnage on oils stocks...sticking with them for now 🙄
#eua Japanese director appointed...interesting! 🏯
#pfc #odx strong 💪
#copl RTO return Apr with 300% re-rate 🎆
#syme #brh #rms #zoe #mcx #clp #gst #trd hold 😑
WeeSportsBet@WeeSportsBet
PF Update: Just one stock to go for this week....#88e #EEENF Results due very very very very soon.....😎
English

@sharetips6 Everything in $ just a typo then converts in table using a factor of 0.73 for USD/£
English

#COPL Figures r mind blowing running costs @ £17.5 per barrel & $7.5 finance payback. Costs high but overestimate & when lower it’s a bonus Was a brilliant deal at $39per barrel now fluctuating between $60-65 Target 10,500bopd should blast to this a beyond with miscible flooding


English




